PNU 282987 50mg 50mg | Purity Not Available
Adooq Bioscience
PNU 282987 (PNU-282,987)is a drug that acts as a potent and selective agonist for the ??7 subtype of neural nicotinic acetylcholine receptors.
More Information Supplier PagePNU 282987 (PNU-282,987)is a drug that acts as a potent and selective agonist for the ??7 subtype of neural nicotinic acetylcholine receptors.
More Information Supplier PagePNU 282987 (PNU-282,987)is a drug that acts as a potent and selective agonist for the ??7 subtype of neural nicotinic acetylcholine receptors.
More Information Supplier PagePNU 282987 (PNU-282,987)is a drug that acts as a potent and selective agonist for the ??7 subtype of neural nicotinic acetylcholine receptors.
More Information Supplier PagePNU 282987 (PNU-282,987)is a drug that acts as a potent and selective agonist for the ??7 subtype of neural nicotinic acetylcholine receptors.
More Information Supplier PageTroxacitabine is a nucleoside analogue with anticancer activity. Its use is being studied in patients with refractory lymphoproliferative diseases.
More Information Supplier PageTroxacitabine is a nucleoside analogue with anticancer activity. Its use is being studied in patients with refractory lymphoproliferative diseases.
More Information Supplier PageA 803467 is a selective blocker of NaV1.8 channels (IC50 values are 8, 2450, 6740, 7340 and 7380 nM for hNaV1.8, hNaV1.3, hNaV1.7, hNaV1.5 and hNaV1.2 channels respectively).
More Information Supplier PageA 803467 is a selective blocker of NaV1.8 channels (IC50 values are 8, 2450, 6740, 7340 and 7380 nM for hNaV1.8, hNaV1.3, hNaV1.7, hNaV1.5 and hNaV1.2 channels respectively).
More Information Supplier PageTAK-285 is an investigational HER2/EGFR inhibitor that penetrates the CNS in Rats with an Intact Blood Brain Barrier (BBB).
More Information Supplier PageTAK-285 is an investigational HER2/EGFR inhibitor that penetrates the CNS in Rats with an Intact Blood Brain Barrier (BBB).
More Information Supplier Page